Skip to Content
Merck
  • Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.

European radiology (2012-08-07)
Henrik S Thomsen, Sameh K Morcos, Torsten Almén, Marie-France Bellin, Michele Bertolotto, Georg Bongartz, Olivier Clement, Peter Leander, Gertraud Heinz-Peer, Peter Reimer, Fulvio Stacul, Aart van der Molen, Judith A W Webb
ABSTRACT

To update the guidelines of the Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) on nephrogenic systemic fibrosis and gadolinium-based contrast media. Topics reviewed include the history, clinical features and prevalence of nephrogenic systemic fibrosis and the current understanding of its pathophysiology. The risk factors for NSF are discussed and prophylactic measures are recommended. The stability of the different gadolinium-based contrast media and the potential long-term effects of gadolinium in the body have also been reviewed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Gadolinium, chips
Sigma-Aldrich
Gadolinium, −40 mesh, 99% trace rare earth metals basis
Sigma-Aldrich
Gadolinium, ingot, 99.9% trace rare earth metals basis
Sigma-Aldrich
Gadolinium, foil, thickness 1 mm, 99.9% trace rare earth metals basis